|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:affects
|
humans
|
|
gptkbp:alternativeName
|
morbilli
rubeola
|
|
gptkbp:causedBy
|
gptkb:Measles_virus
|
|
gptkbp:commonIn
|
children
|
|
gptkbp:complication
|
gptkb:pneumonia
diarrhea
ear infection
encephalitis
|
|
gptkbp:contagiousPeriod
|
4 days before to 4 days after rash
|
|
gptkbp:diagnosedBy
|
PCR
serology
clinical evaluation
|
|
gptkbp:discoveredBy
|
gptkb:Ibn_Razi
|
|
gptkbp:eradicationStatus
|
not eradicated
|
|
gptkbp:family
|
gptkb:Paramyxoviridae
|
|
gptkbp:firstDescribed
|
9th century
|
|
gptkbp:genus
|
gptkb:Morbillivirus
|
|
gptkbp:ICD-10_code
|
B05
|
|
gptkbp:incubationPeriod
|
10-14 days
|
|
gptkbp:KoplikSpots
|
present
|
|
gptkbp:mortalityRate
|
0.1% to 0.2% in developed countries
up to 10% in developing countries
|
|
gptkbp:notableOutbreaks
|
gptkb:2014_Philippines_outbreak
gptkb:2017_Romania_outbreak
gptkb:2019_US_outbreak
|
|
gptkbp:notifiableDisease
|
yes
|
|
gptkbp:prevention
|
gptkb:MMR_vaccine
|
|
gptkbp:R0
|
12-18
|
|
gptkbp:relatedTo
|
gptkb:mumps
gptkb:rubella
|
|
gptkbp:season
|
late winter to early spring
|
|
gptkbp:symptom
|
fever
cough
conjunctivitis
rash
runny nose
|
|
gptkbp:transmission
|
direct contact
airborne droplets
|
|
gptkbp:treatment
|
gptkb:vitamin_A
supportive care
|
|
gptkbp:vaccineCoverageNeededForHerdImmunity
|
95%
|
|
gptkbp:vaccineIntroduced
|
1963
|
|
gptkbp:vaccineSchedule
|
first dose at 12-15 months
second dose at 4-6 years
|
|
gptkbp:vaccineType
|
live attenuated
|
|
gptkbp:WHORegion
|
global
|
|
gptkbp:bfsParent
|
gptkb:disease
gptkb:Vaccination
|
|
gptkbp:bfsLayer
|
4
|